Asieris Pharma asieris.cn


Public lists: Pharma Startups (6570)

Asieris Pharma (亚虹医药) is a Chinese company focused on cancer. The company is developing a repurposed oral inhibitor of MetAP2, a spectrum antibiotic that has been shown to have an anti-angiogenesis effect. It will be tested as a treatment for patients with relapsed non-muscle invasive bladder cancer (NMIBC).

Asieris Pharma (亚虹医药) is a Chinese company focused on cancer. The company is developing a repurposed oral inhibitor of MetAP2, a spectrum antibiotic that has been shown to have an anti-angiogenesis effect. It will be tested as a treatment for...Show all

Company (Alive / Active)

Phone: 0523-8620-1516

Fax:

Suite 705, Twin Towers
China Medical City, Jiangsu Province
Taizhou, 225300
Zhejiang , China

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Asieris Pharma $15M Dec 27, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Asieris Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Base addition salts of nitroxoline and uses thereof Mar 17, 2014 Sep 12, 2017 Patent